These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
3. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study. Prien RF; DeLong SL; Cole JO; Levine J Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574 [No Abstract] [Full Text] [Related]
4. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures. Thaler JS; Curinga R; Kiracofe G Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
6. Toxic anterior segment syndrome after cataract surgery secondary to subconjunctival gentamicin. Litwin AS; Pimenides D J Cataract Refract Surg; 2012 Dec; 38(12):2196-7. PubMed ID: 23195258 [No Abstract] [Full Text] [Related]
7. Incidence and significance of chlorpromazine-induced eye changes. De Long SL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741 [No Abstract] [Full Text] [Related]
8. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment]. Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388 [No Abstract] [Full Text] [Related]
9. A Case Report: Anti-Psychotic Agents Related Ocular Toxicity. Choy BNK; Ng ALK; Shum JWH; Fan MCY; Lai JSM Medicine (Baltimore); 2016 Apr; 95(15):e3360. PubMed ID: 27082594 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous and ocular changes associated with the use of chlorpromazine. Wolf ME; Richer S; Berk MA; Mosnaim AD Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679 [TBL] [Abstract][Full Text] [Related]
11. [Ocular changes in long-term treatment with Largactil]. Kalberer M; Atar Z; Bider E Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755 [No Abstract] [Full Text] [Related]
12. Phenothiazines and eye complications. Valentine M; Jardine P Br Med J; 1966 Sep; 2(5513):586. PubMed ID: 5917372 [No Abstract] [Full Text] [Related]
13. Ocular and cutaneous side effects after prolonged chlorpromazine treatment. Gombos GM; Yarden PE Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858 [No Abstract] [Full Text] [Related]
15. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication. Rasmussen K; Kirk L; Faurbye A Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751 [TBL] [Abstract][Full Text] [Related]
16. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
17. Perfluorohexyloctane, pseudohypopyon, and acute glaucoma. Sampat V; Jones L; Harvey R; Hero M Retina; 2003 Feb; 23(1):122-3. PubMed ID: 12652250 [No Abstract] [Full Text] [Related]
18. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]